Inhibitors

Cyanide is a potent enzyme inhibitor that blocks critical enzymes involved in cellular respiration, leading to severe impairment of ATP production. The other options are incorrect. Concept tested: Medical and biochemical significance of enzyme inhibition.**

Increasing enzyme concentration provides more active sites, allowing more substrate molecules to bind despite the presence of the inhibitor. Concept tested: Effect of enzyme concentration on inhibition.

Irreversible inhibitors permanently inactivate enzyme molecules. Cells regain activity only by producing new enzymes. Extra substrate cannot restore function. Concept tested: Consequences of irreversible inhibition.

A non-competitive inhibitor lowers the maximum reaction rate regardless of substrate concentration because it alters enzyme structure. Competitive inhibition can be overcome by excess substrate. Concept tested: Interpretation of enzyme kinetics.

Enzyme inhibitors regulate metabolic pathways, preventing excessive or unnecessary reactions and maintaining homeostasis. The other options have no physiological basis. Concept tested: Metabolic regulation.

Non-competitive inhibitors bind at an allosteric site, altering enzyme shape and reducing activity regardless of substrate concentration. Other options do not correctly describe this inhibition. Concept tested: Allosteric regulation.

Competitive inhibitors closely resemble the substrate, allowing them to occupy the enzyme's active site. Similarity to products or coenzymes is not responsible for competitive inhibition. Concept tested: Structure-function relationship.

Since increasing substrate fails to restore activity, the inhibitor likely binds outside the active site and changes enzyme conformation. Competitive inhibition would be overcome by excess substrate. Concept tested: Interpretation of experimental data.

Irreversible inhibitors form stable covalent or very strong bonds with enzymes, permanently inactivating them. Other options are inconsistent with irreversible inhibition. Concept tested: Irreversible inhibition.

Heavy metals such as mercury and lead bind to sulfhydryl (-SH) groups, distorting enzyme structure and causing irreversible inhibition. The remaining options are incorrect mechanisms. Concept tested: Heavy metal inhibition.

Many enzyme inhibitors regulate metabolic pathways by controlling enzyme activity. The other options do not represent normal biological roles of inhibitors. Concept tested: Physiological importance of inhibitors.

Excess substrate successfully competes with a competitive inhibitor, increasing enzyme activity. This effect is not observed with non-competitive or irreversible inhibitors. Concept tested: Experimental reasoning.

Non-competitive inhibitors decrease the maximum reaction rate because some enzyme molecules become inactive regardless of substrate concentration. The other statements are incorrect. Concept tested: Effect on enzyme kinetics.

Many medicines work by selectively inhibiting enzymes. Examples include drugs that inhibit bacterial enzymes or enzymes involved in cholesterol synthesis. The remaining options are biologically incorrect. Concept tested: Medical application of enzyme inhibitors.

Competitive inhibitors resemble the substrate and compete for the enzyme's active site. Allosteric sites are involved in non-competitive inhibition, while coenzymes and products are not the primary binding sites for competitive inhibitors. Concept tested: Active site specificity.

Non-competitive inhibitors bind at an allosteric site and alter the enzyme's three-dimensional shape, reducing catalytic efficiency. They do not necessarily destroy the substrate or all proteins. Concept tested: Mechanism of non-competitive inhibition.

Heavy metals such as lead commonly inhibit enzymes by binding strongly to functional groups, causing irreversible loss of activity. They neither serve as coenzymes nor enhance enzyme synthesis. Concept tested: Heavy metal inhibition.

Increasing substrate concentration increases the likelihood of substrate binding instead of inhibitor binding, restoring enzyme activity. The remaining options are biologically incorrect. Concept tested: Reversibility of competitive inhibition.

Reversible inhibitors regulate metabolic pathways according to cellular needs. Permanent inactivation is characteristic of irreversible inhibitors rather than reversible regulation. Concept tested: Physiological regulation.